Cargando…
Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients
Raltegravir (RLT) prevents the integration of HIV DNA in the nucleus, but published studies remain controversial, suggesting that it does not decrease proviral DNA. However, there are only a few studies focused on virus-targeted cells. We aimed our study on the impact of RLT inclusion on total intra...
Autores principales: | Kumar, Gaurav, Cottalorda-Dufayard, Jacqueline, Garraffo, Rodolphe, De Salvador-Guillouët, Francine, Cua, Eric, Roger, Pierre-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773801/ https://www.ncbi.nlm.nih.gov/pubmed/35053324 http://dx.doi.org/10.3390/cells11020208 |
Ejemplares similares
-
COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated
por: Risso, Karine, et al.
Publicado: (2017) -
The expansion of CD4(+)CD28(- )T cells in patients with rheumatoid arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2003) -
Decreased Expression of T-Cell Costimulatory Molecule CD28 on CD4 and CD8 T Cells of Mexican Patients with Pulmonary Tuberculosis
por: Bernal-Fernandez, German, et al.
Publicado: (2010) -
The Story of CD4(+)CD28(−) T Cells Revisited: Solved or Still Ongoing?
por: Maly, Kathrin, et al.
Publicado: (2015) -
CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells
por: Mitra, Ankita, et al.
Publicado: (2020)